2 MONTHS REMAIN FOR NOVO NORDISK A/S INVESTORS: Hagens Berman Alerts Novo Nordisk Investors to Securities Class Action and Lead Plaintiff Deadline

Seattle, Washington, UNITED STATES

SAN FRANCISCO, Jan. 12, 2017 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in Novo Nordisk A/S (NYSE:NVO) to the securities class action lawsuit filed in the U.S. District Court for the District of New Jersey and to the March 13, 2017 Lead Plaintiff deadline.

If you purchased or otherwise acquired NVO between April 30, 2015 and October 27, 2016 and suffered over $200,000 in losses contact Hagens Berman Sobol Shapiro LLP.  For more information visit:


or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing NVO@hbsslaw.com.

After repeatedly assuring investors of sales and profit growth, NVO announced its second consecutive quarter of disappointing earnings and slashed long-term profit-growth forecasts by 50% on October 28, 2016.  In addition, NVO revealed it was being investigated by the U.S. Attorney’s Office for potentially improper arrangements with pharmacy benefits managers who purchase NVO’s insulin products.  This news drove the price of the Company’s ADRs down approximately 13%.

“We’re focused on NVO’s insulin--and other--pricing matters and Defendants’ growth-related statements,” said Hagens Berman partner Reed Kathrein.

Whistleblowers: Persons with non-public information regarding NVO should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.  For more information, call Reed Kathrein at 510-725-3000 or email NVO@hbsslaw.com.

About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. Read the Firm’s Securities Newsletter, and visit the blog. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.


Contact Data